Effect of toxoplasmic infection on the biodistribution of a brain radiopharmaceutical

References

• Andrade GMQ, Vasconcelos-Santos DV, Carellos EVM, Romanelli RMC, Vitor RWA, Carneiro ACAV, Januario JN. 2010. Toxoplasmose congênita em filho de mãe cronicamente infectada com reativação de retinocoroidite na gestação. J Pediatr (Rio J). 86:85–88.
   PubMed Web of Science ®Google Scholar
• Backer W. 2005. The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med. 22:1195–1211.
   Google Scholar
• Barbosa VSA, Holanda C, Câmara ACJ, Silva RP, Oliveira DP, Moreira JA, Azevêdo IM, Medeiros AC. 2009. Trypanosoma cruzi: biodistribution of technetium-99m pertechnetate in infected rats. Exp Parasitol. 123:309–312.
   PubMed Web of Science ®Google Scholar
• Barbosa MA, Angelin LG, Issamu GA, Saikawa C, Oliveira JC, Silva SS. 2015a. Potenciais alternativas terapêuticas em estudo para a toxoplasmose congênita: uma revisão bibliográfica. Rev Pat Trop. 44:1–11.
   Google Scholar
• Barbosa VSA, Lisboa MJS, Sampaio TBM, Lima H, Holanda C, Medeiros AC. 2015b. Effect of antimalarial chloroquine on the biodistribution of sodium pertechnetate in Swiss mice. J Surg Clin Res. 5:100–108.
   Google Scholar
• Bernardo-Filho M, Silva JRM, Reis RJN, Boasquevisque EM, Hasson-Voloch A. 1992. Conditions for labeling of Schistosoma mansoni cercaria with technetium-99m. J Nucl Biol Med. 36:56–59.
   PubMedGoogle Scholar
• Bernardo-Filho M, Pires ET, Boasquevisque EM, Hasson-Voloch A. 1993. Studies on the incorporation of 99m-technetium to the platyhelminth Dugesia tigrina. Rev Parass. 44:7–11.
   Google Scholar
• [CDC] Centers for Disease Control and Prevention: toxoplasmosis, biology. 2015a. [accessed 2018 Jan 22]. http://www.cdc.gov/parasites/toxoplasmosis/biology.html.
   Google Scholar
• [CDC] Centers for Disease Control and Prevention: toxoplasmosis. 2015b. [accessed 2018 Feb 03]. http://www.cdc.gov/parasites/toxoplasmosis/.
   Google Scholar
• Clementino-Andrade MM, Pinheiro BV, Cunha MM, Carneiro A, Andrade-Neto V, Vitor R. 2013. New gentotypes of Toxoplasma gondii obtained from farm animals in Northeast Brazil. Res Vet Sci. 94:587–589.
   PubMed Web of Science ®Google Scholar
• Dabritz HA, Conrad PA. 2010. Cats and Toxoplasma: implications for public health. Zoonoses Public Health. 57:34–52.
   PubMed Web of Science ®Google Scholar
• Feustel SM, Meissner M, Liesenfeld O. 2012. Toxoplasma gondii and the blood-brain barrier. Virulence 3:182–192.
   PubMed Web of Science ®Google Scholar
• Furrer H, Opravil M, Bernasconi E, Telenti A, Egger M. 2000. Stopping primary prophylaxis in HIV-1-infected patients at high risk of Toxoplasma encephalitis. Swiss HIV Cohort Study. Lancet. 355:2217–2228.
   PubMed Web of Science ®Google Scholar
• Holanda CMCX, Barbosa VSA, Lisboa MJS, Lima HLCSM, Silva NB, Melo LMB, Andrade-Neto VF, Medeiros AC. 2015. The malarial infection can alter the normal biodistribution of a radiopharmaceutical? J Surg Clin Res. 5:69–79.
   Google Scholar
• Holanda C, Leite RCH, Nunes RAS, Oliveira HA, Catanho M, Souza G, Bernardo-Filho M. 2006. Effect of antimalarial drugs on the bioavailability of the methylenediphosphonic acid labeled with technetium99m (99mTc-MDP) in Wistar rats. Braz Arch Biol Technol. 49:207–214.
   Web of Science ®Google Scholar
• Jones EJ, Korcsmaros T, Carding SR. 2017. Mechanisms and pathways of Toxoplasma gondii transepithelial migration. Tissue Barriers. 5:e1273865.
   PubMed Web of Science ®Google Scholar
• Kapucu ÖL, Nobili F, Varrone A, Booij J, Vander Borght T, Någren K, Darcourt J, Tatsch K, Van Laere KJ. 2009. EANM procedure guideline for brain perfusion SPECT using 99mTc-labeled radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 36:2093–2102.
   PubMed Web of Science ®Google Scholar
• Kaye A. 2011. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. J Ped Health Care. 25:355–364.
   PubMed Web of Science ®Google Scholar
• Kliegman RM, Stanton BF, Schor NF, Geme JW, Behrman RE. 2014. Nelson Tratado de Pediatria. 19th ed. Rio de Janeiro (RJ): Elsevier; p. 1206–1214.
   Google Scholar
• Lee SH, Choi CW, Kim JH, Rhee CH, Lim SM. 1998. Increased uptake of 99mTc-HMPAO in necrotic brain tumors. J Korean Med Sci. 13:529–532.
   PubMedGoogle Scholar
• Martins JCM, Cruzeiro MM, Pires LA. 2015. Neurotoxoplasmosis and neurocysticercosis in patient with AIDS – case report. Rev Neur. 23:443–450.
   Google Scholar
• Mc Auley JB. 2014. Congenital toxoplasmosis. J Ped Infect Dis Soc. 3:30–35.
   Google Scholar
• Mendes NHD, Oliveira CBS, Garcia CA, Holanda CM, Andrade- Neto VF. 2014. Epidemiological and serological profiles of ocular toxoplasmosis in the municipality of Natal, northeastern Brazil. Trans Royal Soc Trop Med Hyg. 108:656–661.
   PubMed Web of Science ®Google Scholar
• Oliveira CBS, Meurer YSR, Andrade JMA, Costa M, Andrade MMC, Silva LA, Lanza DCF, Vítor RWA, Andrade-Neto VF. 2016. Pathogenicity and phenotypic sulfadiazine resistance of Toxoplasma gondii isolates obtained from livestock in northeastern Brazil. Mem Inst Oswaldo Cruz. 111:391–398.
   PubMed Web of Science ®Google Scholar
• Pereira KS, Franco RMB, Leal D. 2010. Transmission of toxoplasmosis (Toxoplasma gondii) by foods. Adv Food Nutr Res. 60:1–19.
   PubMedGoogle Scholar
• Pomares C, Montoya JG. 2016. Laboratory diagnosis of congenital toxoplasmosis. J Clin Microbiol. 54:2448–2454.
   PubMed Web of Science ®Google Scholar
• Saha GB. 2010. Fundamentals of nuclear pharmacy. 4th ed. New York (NY): Spring-Verlag.
   Google Scholar
• Skiest DJ. 2002. Focal neurological disease in patients with acquired immunodeficiency syndrome. J Infect. 34:103–115.
   Google Scholar
• Torgerson PR, Mastroiacovo P. 2013. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 91:501–508.
   PubMed Web of Science ®Google Scholar
• Weiss LM, Dubey JP. 2009. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 39:895–901.
   PubMed Web of Science ®Google Scholar
• Xavier Holanda CMC, Cavalcanti Jales RL, Almeida Catanho MTJ, Holanda Leite RC, Lopes de Brito LM, Jales-Junior LH, Brandao KC, Amorim LF, de Brito Tiago GG, Gomes ML, et al. 2002. Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats. Cell. Mol. Biol. (Noisy-le-grand). 48:761–765.
   PubMed Web of Science ®Google Scholar